HIF1A and cancer: As infiltrated immune cells residing in the TME are one of the major determining factors for cancer progression and treatment resistance, we next analyzed the components of the infiltrated immune cells in clinical patient samples with high HIF1A-AS2 versus low HIF1A-AS2 using data from TCGA.